Defence Therapeutics Inc. | WebDisclosure

Basculer en Français

9842	Companies
197765	Keywords
128853	Articles
105186	Press releases

Headlines Articles Press releases Defence Therapeutics Inc.

Home
Companies
Defence Therapeutics Inc.

PRESS RELEASE

published on 06/17/2024 at 08:00, 1 year 7 months ago

DEFENCE’S CHIEF SCIENTIFIC OFFICER DR. MOUTIH RAFEI DISCUSSES THE ACCUM PLATFORM FOR CANCER TREATMENTS ON MONEY TALK RADIO WITH ELLIS MARTIN
Defence Therapeutics Inc.'s Chief Scientific Officer Dr. Moutih Rafei discusses the ACCUM platform for cancer treatments on Money Talk Radio with Ellis Martin

Defence Therapeutics Inc. Cancer Treatments ACCUM Platform Dr. Moutih Rafei Money Talk Radio
BRIEF

published on 06/10/2024 at 08:05, 1 year 8 months ago

Defence Therapeutics participera au congrès annuel 2024 du SNMMI à Toronto

Thérapeutique De Défense SNMMI AccuTRIC™ Médecine Nucléaire Imagerie Moléculaire
BRIEF

published on 06/10/2024 at 08:05, 1 year 8 months ago

Defence Therapeutics to Attend 2024 SNMMI Annual Meeting in Toronto

Defence Therapeutics Nuclear Medicine SNMMI AccuTRIC™ Molecular Imaging
PRESS RELEASE

published on 06/10/2024 at 08:00, 1 year 8 months ago

DEFENCE TO PARTICIPATE TO 2024 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING ANNUAL MEETING IN TORONTO ON JUNE 11, 2024
Defence Therapeutics Inc. to participate in the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting in Toronto on June 11, 2024, presenting their novel Radio-Immuno-Conjugate (RIC) for cancer treatment

Cancer Treatment Defence Therapeutics Inc. Molecular Imaging Society Of Nuclear Medicine Radio-Immuno-Conjugate
BRIEF

published on 06/06/2024 at 08:05, 1 year 8 months ago

L'étude AccuTOX de Defense Therapeutics publiée dans le Journal of Translational Medicine

Immunothérapie Essais Cliniques Thérapeutique De Défense AccuTOX Anti-cancer
BRIEF

published on 06/06/2024 at 08:05, 1 year 8 months ago

Defence Therapeutics' AccuTOX Study Published in Journal of Translational Medicine

Clinical Trials Immunotherapy Defence Therapeutics AccuTOX Anti-cancer
PRESS RELEASE

published on 06/06/2024 at 08:00, 1 year 8 months ago

DEFENCE’S ACCUTOX PUBLISHED IN THE PRESTIGIOUS JOURNAL OF TRANSLATIONAL MEDICINE ITS PEER STUDY WITH PRECLINICAL DATA ON ACCUTOX AS AN ANTI-CANCER MOLECULE
Defence Therapeutics Inc.'s AccuTOX published in the prestigious Journal of Translational Medicine along with preclinical data on AccuTOX as an anti-cancer molecule. Study highlights AccuTOX's superior therapeutic properties and versatility for different cancer treatments

Preclinical Data Defence Therapeutics Inc. AccuTOX Journal Of Translational Medicine Anti-cancer Molecule
BRIEF

published on 05/14/2024 at 08:05, 1 year 8 months ago

Defence Therapeutics étend son portefeuille de brevets à l'échelle mondiale

Thérapeutique De Défense Délivrance De Brevet Innovation Dans Les Soins De Santé Vaccin Immuno-oncologique Système De Délivrance De Médicaments
BRIEF

published on 05/14/2024 at 08:05, 1 year 8 months ago

Defence Therapeutics Expands Patent Portfolio Globally

Defence Therapeutics Patent Issuance Drug Delivery System Innovation In Healthcare Immune-Oncology Vaccine
PRESS RELEASE

published on 05/14/2024 at 08:00, 1 year 8 months ago

DEFENCE THERAPEUTICS STRENGTHENS AND EXPANDS GLOBAL PATENT PROTECTION ON KEY TECHNOLOGIES
Defence Therapeutics strengthens and expands global patent protection on key technologies, including vaccine enhancer platform and ADC platform technology. The new patents and allowances showcase the company's commitment to innovation in biopharmaceuticals

Biopharmaceuticals Defence Therapeutics Patent Protection Vaccine Enhancer ADC Platform Technology

Accesswire

Published on 02/12/2026 at 02:30, 43 minutes ago

Zeus North America Mining Corp. Announces Repricing of Private Placement
Published on 02/12/2026 at 01:35, 1 hour 38 minutes ago

Gemdale Gold Engages Independent Trading Group as Market Maker
Published on 02/11/2026 at 23:00, 4 hours 13 minutes ago

Reeflex Solutions Inc. Provides Bi-Weekly Status Update On MCTO
Published on 02/11/2026 at 23:00, 4 hours 13 minutes ago

FutureGen Industries Announces Closing of Private Placement
Published on 02/11/2026 at 22:30, 4 hours 43 minutes ago

Battery X Metals Announces Strategic Sale of Gold & Copper Project Consistent with Its 360° Battery Metals Value Chain Strategy Encompassing Exploration, Rebalancing and Recycling in Support of the Energy Transition

View all ACCESSWIRE

EQS Group

Published on 02/12/2026 at 03:00, 12 minutes ago

Sands China, Alipay and Macau Pass Deepen Partnership to Drive Digital Upgrade
Published on 02/11/2026 at 19:52, 7 hours 21 minutes ago

LR Health & Beauty SE lays foundation for positive future business performance with new financing structure
Published on 02/11/2026 at 19:50, 7 hours 22 minutes ago

EQS-Adhoc: LR HEALTH & BEAUTY SE REACHES AN AGREEMENT WITH BONDHOLDERS AND SHAREHOLDER REGARDING A COMPREHENSIVE RESTRUCTURING OF THE 2024/2028 BOND – EUR 20 MILLION IN NEW CAPITAL AND ...
Published on 02/11/2026 at 18:31, 8 hours 42 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/11/2026 at 18:00, 9 hours 13 minutes ago

Private Equity Holding AG: Net Asset Value as of January 31, 2026

Les Echos

Published on 02/11/2026 at 17:45, 9 hours 28 minutes ago

Infotel : Stake held in AeroEx. A publisher of digital compliance and safety solutions for the aerospace industry.
Published on 02/11/2026 at 17:45, 9 hours 28 minutes ago

Infotel : Prise de participation dans AeroEx éditeur de solutions digitales de conformité et de sécurité pour l’industrie aéronautique.
Published on 02/11/2026 at 11:25, 15 hours 47 minutes ago

Innelec : Mise à disposition du rapport financier semestriel 2025-26
Published on 02/11/2026 at 08:00, 19 hours 13 minutes ago

Imerys-press-release French State acquisition stake Emili Lithium
Published on 02/11/2026 at 08:00, 19 hours 13 minutes ago

Imerys-communique-de-presse prise participation Etat Français Projet lithium Emili

View all LES ECHOS COMFI WIRE